Posted on Jan 10, 2021 at 4:00 p.m.Updated Jan 10, 2021, 6:34 PM
Everything can go very quickly in the vaccine industry. With unfortunate setbacks (the delay of Sanofi) which complicates the vaccination campaign, or conversely, good surprises. The balance tipped in the right direction at the end of last week.
First, thanks to the new order for 300 million doses of the Pfizer Bio NTech vaccine by the European Commission, announced on Friday, in addition to the 300 million already reserved. This is a pre-agreement for a firm order of 200 million plus an optional 100 million.